Bicycle Therapeutics
BCYC
85 hedge funds and large institutions have $618M invested in Bicycle Therapeutics in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 28 reducing their positions, and 12 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
24% more capital invested
Capital invested by funds: $499M → $618M (+$120M)
11% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 28
2.27% more ownership
Funds ownership: 78.48% → 80.75% (+2.3%)
4% less funds holding
Funds holding: 89 → 85 (-4)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
97% less call options, than puts
Call options by funds: $171K | Put options by funds: $5.29M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$24.2M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$9.29M |
| 3 |
PBA
Paradigm Biocapital Advisors
New York
|
+$3.92M |
| 4 |
AC
Armistice Capital
New York
|
+$3.25M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.53M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$5.81M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$5.34M |
| 4 |
Janus Henderson Group
London,
|
-$4.48M |
| 5 |
TCM
Tybourne Capital Management
Hong Kong
|
-$2.95M |
BCYC Hedge Fund Activity: Q2 2023 in Review
85 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q2 2023, worth a combined $618M — up 24% from $499M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of BCYC and 8 opened new positions — a net loss of 4 holders — while 28 trimmed existing stakes and 31 added.
The largest buyer was First Light Asset Management, adding an estimated $24.2M. The largest seller was Point72 Asset Management, cutting an estimated $7.53M.
- 85 institutional investors held Bicycle Therapeutics (BCYC) as of Q2 2023, down from 89 in Q1 2023.
- Funds reported $618M of Bicycle Therapeutics stock for Q2 2023, up 24% quarter-over-quarter.
- 8 funds opened new Bicycle Therapeutics positions in Q2 2023 and 12 closed out, a net change of -4 holders.
- The largest Bicycle Therapeutics buyer in Q2 2023 was First Light Asset Management, an estimated $24.2M added.
- The largest Bicycle Therapeutics seller in Q2 2023 was Point72 Asset Management, an estimated $7.53M sold.
Based on aggregated 13F filings for Q2 2023.